XNYS · ABT

+1.87% · +$1.85 · Vol 19.9M

Market closed · last close 4:00 PM ET · price as of 19:00:00 ET

Abbott Laboratories

PHARMACEUTICAL PREPARATIONS

$100.68

Card

Relationship Map

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is ABT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move ABT next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 17
Score
Score moved +4
69/BUY BIAS -> 73/BUY BIAS
Veridion score historySource
Jul 12
CongressChecking access
Hon. Rick Larsen sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 9
CongressChecking access
Richard Dean Dr Mccormick purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 9
CongressChecking access
Richard Dean Dr Mccormick purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 6
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 6
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

Catalyst calendar

Dated receipts for ABT are being assembled.

About Abbott Laboratories

PHARMACEUTICAL PREPARATIONS

Listed since

1949

Employees

115K

Country

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$101.00

Day high

$102.13

Day low

$99.47

Previous close

$98.83

52W high

$136.62

-26.31% from high

52W low

$82.56

34% of range

Market cap

$175.4B

P/E

30.33×

EPS

$3.32

Beta

0.06

Shares out

1.7B

Volume

19.9M

1.38× rel vol

Avg volume

14.4M

VWAP

$100.70

Price history computed in-house

+9.30%

+13.88%

+8.58%

-18.59%

YTD

-19.64%

SMA 50 $89.66 · above

SMA 200 $109.83 · below

52W position 34%

Veridion warehouse edge

Warehouse intelligence for ABT.

Veridion Score

Checking plan access.

Congress 30d

Hon. Rick Larsen · Sale

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Related public evidence

Relationship mapTrace receipt-backed holders and filings around ABT.Congress disclosuresOpen receipt and filing context for ABT.MethodologyReview score inputs, coverage rules, and limitations.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

ABT insider activity

Abbott Laboratories

Score

Coverage building

Pressure

Mixed

Filings

Buys / sells

0 / 0

Net value

Not disclosed

Insiders

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ABT.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

SEC Form 4 ledger

Receipt-backed filing rows for ABT are being assembled from the latest scheduled snapshot.

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

ABT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for ABT in this window.

Lobbying spend

ABT lobbying filings, year to date.

Registered lobbying filings matched to Abbott Laboratories.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for ABT in this window.

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Composite trend over time

Why is ABT moving today?

What can move ABT next.

Warehouse intelligence for ABT.

Continue the ABT research trail.

ABT insider activity

ABT contract awards, year to date.

ABT lobbying filings, year to date.

Cross-references from this score page.

What can move ABT next.

ABT insider activity

Cross-references from this score page.